The
Hoodia in HoodiaBites™ contains the only
form of Hoodia that has been clinically tested
in America. This study proved that the median
weight loss over 28 days is 10 pounds with an
average decrease in body fat of 3.3%. This weight
loss is considered a healthy weight loss that
can stay off. The participants interviewed stated
that their caloric intake decreased to less
than half in only a few days of being on the
Hoodia Gordonii used in HoodiaBites™.
The participants in the study
were first categorized as being AT LEAST overweight.
Overweight is defined as being AT LEAST 25 pounds
over their body’s natural weight zone.
30-39 is considered obesity and 40 or greater
is considered severely obese. The requirements
of each participant where as follows:
- Each participant was required
to eat a balanced breakfast with a multivitamin
supplement in the AM.
- Each participant was required
to take 2 Hoodia Gordonii capsules daily.
The first capsule, 1-hour prior to lunchtime
with 8 ounces of water and the second capsule
1 hour prior to dinner with a minimum of 8
ounces of water.
- Each participant was required
to have their weight recorded on days 0, 7,
14, and 28.
The product has not been shown
to interact with any other medications being
taken. No major side effects have been reported.
No other weight loss products were taken during
the 28-day study. Each participant was instructed
not to alter his or her dietary habits. All
participants utilized One (1) Detecto scale.
Each weight was checked by Dr. Goldfarb to ensure
quality control and accuracy. All weights were
entered at the time of weigh in. Compliance
of the participants was excellent. All patients
did not alter their dietary habits and/or their
daily activity during the 28-day study.
CONCLUSION:
This study proved that the median
weight loss over 28 days is 10 pounds with an
average decrease in body fat of 3.3%.
No side effects such as nausea,
vomiting, diarrhea, jitteriness, or change in
sleep habits were reported.
Author contributions Study conception
and design: Richard M. Goldfarb, M.D. FACS Analysis
and interpretation of data: Richard M, Goldfarb,
M.D. FACS Critical revision: David J. Miller,
D.O. FAAP Supervision: David J. Miller, D.O.
FAAP
|